Search

everythinglearnresearchcommunity

for

Search:↓

The hair-growth formula with L-cystine helps protect and grow hair cells.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Women with certain types of hair loss may have low iron levels.

Some drugs can cause hair loss, increase hair growth, or change hair color, but stopping the drug usually reverses these effects.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Washing test helps identify hair loss type, low iron levels significant.

CTE and FPHL are different hair loss types with unique causes.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Low iron levels are linked to hair loss in women.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

The dietary supplement helped increase hair growth in women with hair loss.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.